Discovery of 6-Oxo-3-(2-phenylpyrazolo[1,5-a]pyridin-3-yl)-1(6H)-pyridazinebutanoic Acid (FK 838): A Novel Non-Xanthine Adenosine A1Receptor Antagonist with Potent Diuretic Activity
- 20 February 1999
- journal article
- letter
- Published by American Chemical Society (ACS) in Journal of Medicinal Chemistry
- Vol. 42 (5) , 779-783
- https://doi.org/10.1021/jm980671w
Abstract
No abstract availableThis publication has 15 references indexed in Scilit:
- Synthesis and Biological Evaluation of the Enantiomers of the Potent and Selective A1-Adenosine Antagonist 1,3-Dipropyl-8-[2-(5,6-epoxynorbonyl)]- xanthineJournal of Medicinal Chemistry, 1997
- A1-Adenosine receptor antagonistsExpert Opinion on Therapeutic Patents, 1997
- Discovery of FK453, a novel non-xanthine adenosine A1 receptor antagonistBioorganic & Medicinal Chemistry Letters, 1996
- Renal effects of FK453: A potent non‐xanthine adenosine A1 receptor antagonistDrug Development Research, 1995
- A novel non-xanthine adenosine A1 receptor antagonistEuropean Journal of Pharmacology, 1995
- Natriuretic and hypotensive effect of adenosine-1 blockade in essential hypertension.Hypertension, 1993
- Adenosine receptor subtypesTrends in Pharmacological Sciences, 1993
- Prospective evaluation of a model for the prediction of milk:plasma drug concentrations from physicochemical characteristics.British Journal of Clinical Pharmacology, 1992
- Novel therapeutics acting via purine receptorsBiochemical Pharmacology, 1991
- 8-(Dicyclopropylmethyl)-1,3-dipropylxanthine: a potent and selective adenosine A1 antagonist with renal protective and diuretic activitiesJournal of Medicinal Chemistry, 1991